Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
The oncology company reported weak revenues and lowered guidance due to organizational restructuring and delayed regulatory approvals for its catheter systems. Additionally, the manager...
— Micro Cap Fund Commentary 2
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on TriSalus Life Sciences, Inc.
No other institutional pitches found for this ticker yet.